BCT Ventures secured ₹42 crore in seed funding, led by 3one4 Capital. The Mumbai-based firm is an AI-native venture studio, designed to build and scale multiple consumer nutrition and wellness brands. They've officially launched operations, targeting demand for practitioner-backed preventive healthcare.
The current AI gold rush sees firms like Mykare and Kapture CX integrating AI for operational efficiency and customer experience. Mykare, for instance, pivoted to an agentic AI platform last month, raising $3.2 million after leaving its hospital discovery roots.
Expect BCT Ventures to announce initial brand partnerships or product launches within the next two quarters, given their official launch. The real test will be demonstrating AI-driven cost efficiencies against traditional D2C growth models by early 2025.
🇮🇳 Why This Matters for India
For D2C founders in Bangalore's healthtech space, this signals 3one4 Capital's increased appetite for AI-first venture studios over single-brand plays.
The Take
The real bet here is on AI transforming the venture studio model itself, not just on D2C brands. If BCT Ventures successfully automates brand scaling, it will challenge how early-stage consumer funds typically evaluate new opportunities by late 2025.
Source:  Inc42 ↗